2 results match your criteria: "Republic of Korea. jsw@gilhospital.com.[Affiliation]"
Risks of N95 Face Mask Use in Subjects With COPD.
Respir Care
May 2020
Division of Pulmonology, Allergy and Critical Care, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.
Background: The N95 filtering facepiece respirator (FFR) is the most popular individual protective device to reduce exposure to particulate matter. However, concerns have been raised with regard to its use because it can increase respiratory resistance and dead space. Therefore, this study assessed the safety of N95 use in patients with COPD and air-flow limitation.
View Article and Find Full Text PDFSulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
BMC Pharmacol Toxicol
April 2018
Department of Internal Medicine, Gachon University Gil Medical Center, 21 Namdong-daero 774, Namdong-gu, Incheon, 21565, Republic of Korea.
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with no effective treatment. The epithelial-mesenchymal transition (EMT) is a critical stage during the development of fibrosis. To assess the effect of sulforaphane (SFN) on the EMT and fibrosis using an in vitro transforming growth factor (TGF)-β1-induced model and an in vivo bleomycin (BLM)-induced model.
View Article and Find Full Text PDF